Healthcare resource utilisation and related costs of patients with CKD from the UK: a report from the DISCOVER CKD retrospective cohort.
Carol A PollockGlen JamesJuan Jose Garcia SanchezJuan Jesús CarreroMatthew ArnoldCarolyn Su Ping LamHungta Tony ChenStephen NolanRoberto Pecoits-FilhoDavid C WheelerPublished in: Clinical kidney journal (2022)
HCRU and costs associated with CKD impose a substantial burden on the healthcare system, particularly in the more advanced stages of CKD. New interventions that can delay the progression of CKD to kidney failure may not only prolong the patient's life, but would also provide significant resource and cost savings to healthcare providers.